ArticleMetabolites2024

Utility of an Untargeted Metabolomics Approach Using a 2D GC-GC-MS Platform to Distinguish Relapsing and Progressive Multiple Sclerosis.

Indrani Datta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.